KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for National Health Investors (NHI) over the last 16 years, with Q3 2025 value amounting to $1.5 million.

  • National Health Investors' Amortization of Deferred Charges fell 33.24% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.9 million, marking a year-over-year increase of 1889.94%. This contributed to the annual value of $6.6 million for FY2024, which is 4051.23% up from last year.
  • National Health Investors' Amortization of Deferred Charges amounted to $1.5 million in Q3 2025, which was down 33.24% from $1.7 million recorded in Q2 2025.
  • National Health Investors' Amortization of Deferred Charges' 5-year high stood at $2.1 million during Q4 2024, with a 5-year trough of $262000.0 in Q2 2021.
  • Moreover, its 5-year median value for Amortization of Deferred Charges was $1.2 million (2021), whereas its average is $1.3 million.
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first crashed by 3364.25% in 2021, then surged by 30801.53% in 2022.
  • Over the past 5 years, National Health Investors' Amortization of Deferred Charges (Quarter) stood at $1.1 million in 2021, then fell by 0.56% to $1.1 million in 2022, then grew by 21.18% to $1.3 million in 2023, then surged by 59.4% to $2.1 million in 2024, then decreased by 27.27% to $1.5 million in 2025.
  • Its Amortization of Deferred Charges stands at $1.5 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.7 million for Q1 2025.